Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06259656
NCT06259656
Completed
Not Applicable

Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Vachira Phuket Hospital1 site in 1 country40 target enrollmentOctober 25, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCovid-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid-19
Sponsor
Vachira Phuket Hospital
Enrollment
40
Locations
1
Primary Endpoint
COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.

Detailed Description

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.

Registry
clinicaltrials.gov
Start Date
October 25, 2023
End Date
November 25, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Thai term pregnant women
  • •18-45 year old
  • •At least 1 covid vaccination received
  • •admission at Vachira Phuket Hospital Labor Room

Exclusion Criteria

  • •Do not want to participate
  • •Unstable or Emergency condition

Outcomes

Primary Outcomes

COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level

Time Frame: 1 month

Test for correlation of level in maternal and cord blood

Secondary Outcomes

  • Analysed time effect from last vaccination and type.(1 month)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)COVID-19
NCT04465474Chinese University of Hong Kong3,000
Active, not recruiting
Not Applicable
Evaluation of Humoral Immunity Following COVID-19 in PregnancyCOVID-19Pregnancy RelatedInfluenza, Human
NCT04568044Imperial College London128
Active, not recruiting
Not Applicable
Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at DeliveryCOVID-19
NCT05564884Rabin Medical Center58
Completed
Not Applicable
SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing HomesCOVID-19 Infection
NCT04964024Central Hospital, Nancy, France1,293
Terminated
Phase 2
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections
NCT04432272William Beaumont Hospitals71